We recently published a list of the 13 Most Undervalued Blue Chip Stocks To Buy According To Analysts. In this article, we ...

The Committee for Medicinal Products for Human Use recommends marketing approval for Merck's Keytruda for treating two types ...

Merck (MRK) stock is in focus as a Phase 3 trial for its cancer drug Keytruda in colorectal cancer patients did not meet ...

Ethereum, or 1 ETH, traded at $2,636.77 as of 8 a.m. ET. The highest intraday price the cryptocurrency reached in the past ...

Merck's Phase 3 KEYFORM-007 study on the combination of favezelimab and pembrolizumab in MSS mCRC patients did not improve ...

Merck said on Wednesday its therapy did not meet the main goal of a late-stage trial evaluating it in patients with a type of ...

Merck & Co Inc. (MRK) on Wednesday said its Phase 3 KEYFORM-007 study evaluating the company's drug candidate favezelimab in ...

Merck (MRK) announced the Japanese Ministry of Health, Labor and Welfare has approved new indications for KEYTRUDA or pembrolizumab, ...

Headlines,Wall Street analysts show strong enthusiasm for Merck, (NYSE:MRK),, with the average brokerage recommendation (ABR) ...

Adding these three top-ranked, best-performing, and well-managed mutual funds to your retirement portfolio could maximize your returns. You might want to consider adding these three top-ranked, ...